A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT).
Br J Dermatol
; 179(4): 836-843, 2018 10.
Article
in En
| MEDLINE
| ID: mdl-29355904
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Scalp Dermatoses
/
Diterpenes
/
Facial Dermatoses
/
Keratosis, Actinic
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Br J Dermatol
Year:
2018
Document type:
Article